Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

It's All Off: $160bn PfizerGan Deal Collapses On Latest US Treasury Edicts

This article was originally published in Scrip

Executive Summary

Pfizer Inc. and Allergan PLC have terminated "by mutual agreement" their $160bn merger . The decision was driven by new US Treasury Department rules endorsed by President Barack Obama to prevent tax inversion deals that were announced on April 4, 2016.

Advertisement

Related Content

Allergan's Fishing For Deals, But Don't Expect A Big Catch

Topics

Advertisement
UsernamePublicRestriction

Register